Citric Acid

Citric Acid

SCHEMBL2840328

CN1CCC(Oc2cccc3ccccc23)c2occc2C1.O=C(O)CC(O)(CC(=O)O)C(=O)O

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 known ✓ O00255 1/20 0.33
CHRM3 P20309 2/20 0.36
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 3/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
HPGD P15428 1/20 0.33
PREP P48147 1/20 0.33
KMT2A Q03164 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM1 P11229 1/20 0.33
HCRTR1 O43613 2/20 0.33
HCRTR2 O43614 2/20 0.33
HTR6 P50406 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2838429 0.87 KMT2A (0.39) CHRM3HSD17B10MEN1KMT2ACHRM4
SCHEMBL2841757 0.87 KMT2A (0.39) CHRM3HSD17B10MEN1KMT2ACHRM4
Hydrochloric Acid SCHEMBL2842975 0.86 KMT2A (0.40) KDM4EHSD17B10TDP1MEN1KMT2A
SCHEMBL2841451 0.79 SLC6A2 (0.42) MEN1KMT2A
Citric Acid SCHEMBL2835076 0.78 KDM4E (0.38) ALDH1A1KDM4EMEN1KMT2A
SCHEMBL2840421 0.73 PKM (0.34) CHRM3CHRM4CHRM5CHRM1LMNA
SCHEMBL2846176 0.72 MEN1 (0.38) MEN1KMT2A
SCHEMBL2839108 0.71 SIGMAR1 (0.36) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL2839613 0.71 HRH3 (0.37) HSD17B10PREPMEN1KMT2A
Hydrochloric Acid SCHEMBL2841722 0.70 KMT2A (0.38) KDM4EHSD17B10TDP1PREPMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 MEN1 3895/4885CHRM3 1633/4885ALDH1A1 66/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.